No Data
US Manufacturing Index Rises To 43, Highest Since 2020
Quantum BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)
Quantum Biopharma's Financial Growth and Stability
Quantum Biopharma Announces That Sentinel Dosing Has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US
Quantum BioPharma Closes Private Placement Offering
No Data
No Data